[Bone scintigraphy with 99mTc-methylene diphosphonate in parodontopathy (author's transl)].
In a total of 20 patients (of these 8 without parodontopathy and 12 with parodontitis marginalis profunda), a quantitative scintigraphy of the jaw bones was carried out after application of 99mTc-methylene diphosphonate with a gamma camera computer system. In 8 patients without parodontopathies, approximately the same metabolic activity in the bone was found in the os occipitale as well as in the mandible and maxilla. The 12 patients with parodontitis marginalis profunda showed in contrast to this an appreciable raised bone metabolism in the region of the affected jaw bone. This finding was in agreement with corresponding alterations in the X-ray of the jaw. The use of bone scintigraphy in marginal parodontopathies thus provides in addition to the radiological finding information on processes of bone transformation and degradation which can be registered quantitatively. Digital analysis enables control of the course of therapie.
D000328:Adult; D000368:Aged; D004164:Diphosphonates; D005260:Female; D006801:Humans; D008297:Male; D008334:Mandible / Q000000981:diagnostic imaging*; D008437:Maxilla / Q000000981:diagnostic imaging*; D008875:Middle Aged; D009777:Occipital Bone / Q000000981:diagnostic imaging; D010510:Periodontal Diseases / Q000000981:diagnostic imaging*; D010518:Periodontitis / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D013667:Technetium
D004164:Diphosphonates; D013667:Technetium
Knochenszintigraphie mit 99mTc-Methylen-diphosphonat bei Parodontopathien.